Literature DB >> 9588233

Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria.

J J Andy1, P O Ogunowo, N A Akpan, C O Odigwe, I A Ekanem, R A Esin.   

Abstract

There should be a recognisable trend between the incidence of hypereosinophilia and the duration of tropical endomyocardial fibrosis (EMF), if the hypothesis, that EMF is the burnt out phase of eosinophil associated heart disease, is correct. We tested this hypothesis in a prospective study of 89 consecutive EMF cases over an 18 year period at two Nigerian locations (Ife in South West and Calabar in South East). We carefully dated the duration of EMF symptoms at first presentation and screened for hypereosinophilia (eosinophilia > or = 1500/mm3), and their causes. When no cause was identified for hypereosinophilia we gave a therapeutic trial with diethylcarbamazine to the patients. An eosinophil count > or = 1000/mm3 was recorded in 80% of 24 cases seen within 6 months; 55% of 46 cases seen 0-24 months; 54% of 18 cases seen 25-48 months and 21% of 25 cases seen more than 49 months of onset of symptoms: while the respective distribution of eosinophil count > or = 1500/mm3 for similar periods were 66, 44, 27 and 21%. This reflects a highly significant (P < 0.001) inverse relationship between hypereosinophilia and the duration of EMF and strengthens the concept that EMF (without eosinophilia) represents the late stage of eosinophilic heart disease. The localisation of endemic EMF to the low-lying tropical rain forest Zone and its predominant occurrence among rural dwellers and farmers suggest a vector borne etiologic agent. Microfilaria was the most likely cause of hypereosinophilia in the cases presented.

Entities:  

Mesh:

Year:  1998        PMID: 9588233     DOI: 10.1016/s0001-706x(97)00125-3

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  27 in total

1.  Eosinophil-associated processes underlie differences in clinical presentation of loiasis between temporary residents and those indigenous to Loa-endemic areas.

Authors:  Jesica A Herrick; Simon Metenou; Michelle A Makiya; Cheryl A Taylar-Williams; Melissa A Law; Amy D Klion; Thomas B Nutman
Journal:  Clin Infect Dis       Date:  2014-09-18       Impact factor: 9.079

2.  Myocarditis during acute schistosomiasis in two travelers.

Authors:  Loïc Epelboin; Stéphane Jauréguiberry; Jean-Baptiste Estève; Martin Danis; Michel Komajda; François Bricaire; Eric Caumes
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

3.  Infection-associated Immune Perturbations Resolve 1 Year Following Treatment for Loa loa.

Authors:  Jesica A Herrick; Michelle A Makiya; Nicole Holland-Thomas; Amy D Klion; Thomas B Nutman
Journal:  Clin Infect Dis       Date:  2021-03-01       Impact factor: 9.079

4.  Presence of circulating anti-myosin antibodies in endomyocardial fibrosis.

Authors:  Ana Olga Mocumbi; Najma Latif; Magdi H Yacoub
Journal:  PLoS Negl Trop Dis       Date:  2010-04-20

Review 5.  Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa.

Authors:  Bongani M Mayosi
Journal:  Heart       Date:  2007-10       Impact factor: 5.994

6.  Right ventricular endomyocardial fibrosis presenting with ventricular tachycardia and apical thrombus--an interesting presentation.

Authors:  Amitesh Aggarwal; Bineet Sinha; Surender Rajpal; Shridhar Dwivedi; Vishal Sharma
Journal:  Indian Pacing Electrophysiol J       Date:  2009-11-01

7.  Endomyocardial fibrosis (EMF) in a Ugandan child with advanced hepatosplenic schistosomiasis: coincidence or connection?

Authors:  Amaya L Bustinduy; Kenneth Luzinda; Simon Mpoya; Philip Gothard; Neil Stone; Stephen Wright; J Russell Stothard
Journal:  Am J Trop Med Hyg       Date:  2014-07-07       Impact factor: 2.345

Review 8.  Endomyocardial Fibrosis: an Update After 70 Years.

Authors:  Ana Olga Mocumbi; J Russell Stothard; Paulo Correia-de-Sá; Magdi Yacoub
Journal:  Curr Cardiol Rep       Date:  2019-11-22       Impact factor: 2.931

Review 9.  Gastrointestinal eosinophilia.

Authors:  Li Zuo; Marc E Rothenberg
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

10.  Searching for new clues about the molecular cause of endomyocardial fibrosis by way of in silico proteomics and analytical chemistry.

Authors:  Misaki Wayengera
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.